Background and aims Familial hypercholesterolemia (FH) is characterized by high LDL-
cholesterol (LDL-C) and early atherosclerotic cardiovascular disease (ASCVD). With a lipid …

Background: Familial hypercholesterolemia (FH) carries a high risk of atherosclerotic
cardiovascular disease (ASCVD). As the population ages, the age-related influence on …

Background and aims Familial hypercholesterolemia (FH) variants are associated with
higher atherosclerotic cardiovascular disease risk (ASCVD) even when compared with other …

Background and aims Familial hypercholesterolemia (FH) is a genetic disorder with a high
burden of arteriosclerotic cardiovascular disease. The prevalence of heterozygous FH is …

Background: Heterozygous familial hypercholesterolemia (FH) affects up to 1 in 200
individuals in the United States, but atherosclerotic cardiovascular disease (ASCVD) …

Background Familial hypercholesterolaemia (FH) is a genetic disease characterised by
hypercholesterolaemia and premature cardiovascular events. Early diagnosis and treatment …

Heterozygous familial hypercholesterolemia (FH) is an autosomal codominant genetic
condition characterized by elevated LDL (low-density lipoprotein) cholesterol and increased …

Background Familial hypercholesterolemia (FH) is a common autosomal dominant disease
associated with premature coronary heart disease (CHD). Studies tend to show that patients …

Importance Familial hypercholesterolemia (FH) is a genetic disorder that often results in
severely high low-density lipoprotein cholesterol (LDL-C) and high risk of premature …

Aims Untreated familial hypercholesterolaemia (FH) increases the risk of premature
atherosclerosis and cardiovascular disease (CVD). This study investigated the presence of …